Breast Cancer Test Validated in Lymph Node-Positive Breast Cancer Patients

Agendia BV, world leader in the rapidly evolving field of molecular diagnostics, announced that an independent international consortium has demonstrated the prognostic power of its MammaPrint breast cancer prognosis test in patients who have 1-3 positive lymph nodes.
PR Newswire